Alert for travellers on weight-loss jabs going to the airport as they risk 'serious trouble'
Travel and health experts are advising individuals taking weight-loss injections to exercise caution when travelling abroad, as these medications are prohibited or heavily restricted in certain countries. Despite being approved for use in the UK, including the recent NHS rollout of Mounjaro, other nations have not sanctioned their use, which could lead to confiscation or even detention if attempted to be imported.
Experts recommend researching the regulations of your destination and taking necessary steps to ensure uninterrupted treatment. NHS GP Dr Asimah Hanif explained: "There are countries where weight loss injections are restricted or banned - unlike the UK where they are more widely accepted.
"For example if you were to go to the UAE you would need pre-approval from the Ministry of Health. Or if you were to go to Japan, you would require an import certificate.
"In Singapore - you would need approval from the health services authority before travel. There are many ways you can prepare yourself according to the country you're travelling to.
"This will ensure a smooth journey and also allow you to continue administering your weight loss injections." This is especially critical for individuals relying on these injections for diabetes management, in addition to weight loss.
GP Dr Ola Otulana has stated: "At the moment weight loss injections such as semaglutide are widely prescribed in the UK for diabetes management and now more recently for weight management. However, people may not realise that rules can differ significantly abroad as in some countries (in Asia and the Middle East), medications like semaglutide can be heavily regulated or banned entirely if they are not licensed for weight loss there.
"Even in places where they are legal, carrying injectable medications without a letter from a doctor and proof of prescription can raise issues at customs, which may lead to items being confiscated."
"If you are prescribed a weight loss injection in the UK and are planning to travel, the safest approach is to check the embassy website of your destination country in advance to confirm the rules on your medication. You should also carry your prescription, a formal letter from your GP explaining the indication and dosing, and also keep the medication in its original packaging.
"Some countries require you to declare any injectable or controlled medications when you arrive. Prepare and bring any necessary documentation to avoid stress while travelling / abroad and talk to your GP or pharmacist before travelling."
Travellers have reported encountering problems in several countries where these jabs - and other medicines - could potentially land you in hot water, reports Bristol Live. Isheeta Borkarm, co-owner of Travelicious Couple, warned: " Weight-loss injections like Wegovy are legal and widely used in the UK, but they're not allowed everywhere else.
"We've come across a few countries where bringing them in could actually get you into serious trouble. For example, Japan has extremely strict rules around medication import.
"Even certain asthma inhalers are banned, so bringing in injectable weight-loss medication, especially with a needle, without prior approval could lead to confiscation or worse. Singapore requires prior authorisation for any injectable medication.
"We've heard in Thailand even prescription drugs can be flagged at customs if the paperwork isn't clear."
Experts recommend five steps for those travelling with weight loss jabs:
1. You should check embassy websites for the latest information
2. Carry your prescription and a letter from your doctor (ideally stating dosage and medical necessity).
3. Declare it at customs.
4. Avoid packing injectables in carry-ons. Use the original packaging and keep medication with their official labelling.
5. Some of these medications need refrigeration. Call hotels in advance to ensure they had a minibar fridge.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
BBC News
an hour ago
- BBC News
Derby doctor's errors examined after 101 patient deaths
Errors made by a doctor are being reviewed to establish whether they played a part in the deaths of 101 patients.A former radiology consultant at Royal Derby Hospital has been under review, over cardiac MRI (magnetic resonance imaging) scans, since concerns were raised by cardiology colleagues in November 2020. Documents seen by the Local Democracy Reporting Service (LDRS) showed 1,224 cases between 2013 and 2020, involving the doctor, were looked into as part of the review. The University Hospitals of Derby and Burton NHS Foundation Trust claimed it took an "open and transparent" approach with the public in regards to the review and that "no significant harm" had been identified so far. The initial review – due to be published in full later this year – found while there is an expected discrepancy rate of 5% for cardiac MRI scans, an audit of 63 cases found the doctor's discrepancy rate was 37%. That meant it was seven times the accepted rate, presenting an error with one out of every three scans.A discrepancy rate across the whole 1,224 cases has not been provided. Evidence of 'misdiagnosis' The ongoing review found that out of the 1,224 cases, two cases were found to show "definite omission or misinterpretation with unequivocal potential for serious morbidity or threat to life". Of the cases reviewed, 102 were found to show "definite omission or interpretation of finding with strong likelihood of moderate morbidity but not threat to life".Meanwhile, in 361 cases, "clinical significance of disagreement is debatable or likelihood of harm is low", and in 378 cases there was "disagreement over style and/or presentation of the report including failure to describe insignificant features".A total of 176 patients out of the 1,224 assessed have now died, with a "misreported" cardio MRI scan found in 101 of those patients. The medical examiner will now assess if any of the 101 deceased patient cases showed evidence that their misreported MRI, or any associated subsequent treatment delay, was "likely" to or "could" have "contributed to", "caused" or "accelerated" their patients were contacted by the trust. A total of 120 patients had their cases recalled by the trust for further assessment with evidence of "misdiagnosis" "which will have impacted treatment decisions and pathways".The hospital trust apologised for the impact on patients and indicated training and processes were at fault, but said changes had been made. 'Choices taken away' The review into the doctor was due to conclude in January, then believed to have then shifted to April and is still affected patient, who was seen by the doctor in 2014, called the matter a "monumental failure to manage from trust leadership" and said the review had been badly handled. She said she was notified about her misreported MRI nine years after the scan."We are not going to get the full picture because of how long it has taken. They haven't considered the future prognosis for patients."Nurses rely on diagnoses and care plans and there is potential care here that has not been given."This has taken away my choices. Because I didn't have that knowledge, I couldn't make decisions based on correct information and the people treating me couldn't make correct decisions either because of the misreporting of a scan."It is really, really upsetting."Karen Reynolds, a clinical negligence lawyer at Freeths in Derby, who is representing the patient, added she was "shocked" the review had not come to light sooner. "The trust must now be entirely transparent about this review," she said. "It is their responsibility to uphold the duty of candour and do what they can to reassure patients." The trust said the doctor had left the organisation, adding "no concerns have been found about the individual's other areas of practice".The General Medial Council (GMC) - which regulated doctors - confirmed the doctor was still registered with a licence to practise with no fitness to practise case has been brought before the Medical Practitioners Tribunal Service by the GMC, the MPTS trust said those involved in reviewing the case at the time - which included colleagues external to the organisation - decided it did not meet GMC referral Gis Robinson, the trust's executive chief medical officer, said: "We have re-seen and personally apologised to the 120 patients who have needed to be followed up as part of this review, and while so far the investigation has found no significant harm has been caused, we absolutely apologise again to those affected for the emotional impact this has had and for the extended time this has taken."Though scans are just one of many elements we use to diagnose a patient and variations in how clinicians read them are expected, our investigation has shown our processes were not as strong as they could have been and we have made changes – with scans now being reviewed as part of a multidisciplinary team, and a percentage of scans externally audited as an additional safety measure."Our priority has understandably been communicating with and supporting those who have been directly affected as we have moved through this process, and we will publish a public report as we normally would once the investigation in complete."
Daily Mail
an hour ago
- Daily Mail
The Mounjaro diet: Yes, there ARE foods that work just like the miracle jabs: FAYE JAMES reveals the exact diet to follow to lose weight and silence the noise
There is a quiet frenzy building around the latest wave of injectable weight-loss drugs, and none have garnered more attention than Mounjaro. Known by its generic name, tirzepatide, Mounjaro is a dual-action medication that mimics two powerful gut hormones, GLP-1 and GIP, which together blunt appetite, regulate blood sugar and encourage the body to burn fat more efficiently.
North Wales Chronicle
2 hours ago
- North Wales Chronicle
Covid XFG cases rising: What is known about new strain
Covid XFG, or 'stratus' as it is also known, is a descendant of the Omicron variant and was first detected back in January 2025. It has also been referred to as a "Frankenstein" or "recombinant" strain. Today, WHO's Scientific Advisory Group on the Origins of Novel Pathogens (SAGO), a group convened by WHO, released a report on the origins of SARS-CoV-2, the virus that caused the #COVID19 pandemic. For this report, SAGO reviewed peer-reviewed papers and reviews, as well as… "This means it emerged when a person was infected with two Covid strains at once which then became a new hybrid variant," The Mirror explained. Reports of the new variant are "growing rapidly", according to the World Health Organisation (WHO), and it is showing some signs of "additional immune evasion" compared to others. The WHO has placed Covid stratus "under monitoring" due to the rise in cases worldwide. It is one of seven COVID-19 variants currently being monitored, along with the NB.1.8.1 strain, which is the dominant variant worldwide. The coming COVID-19 Winter Surge in Australia will show the world where we are actually headed is happening in South-Eats Asia and East Asia are just the 'preludes'...watch how NB.1.8.1 spawns are evolving including PQ.1, PQ.2 and even sub-lineages like PE.1. However, the WHO stated that the risk posed by the new variant was "low," and that approved COVID-19 vaccines are expected to be effective against it. The world health experts, in a recent risk evaluation, said: "Several countries in the South-East Asia Region have reported a simultaneous rise in new cases and hospitalisations, where XFG has been widely detected. "Current data do not indicate that this variant leads to more severe illness or deaths than other variants in circulation." The WHO added: "The available evidence on XFG does not suggest additional public health risks relative to the other currently circulating Omicron descendent lineages." Covid Stratus has already been detected in 38 different countries around the world. The WHO added: "The detection of XFG is increasing across several countries in various regions that are consistently sharing SARS-CoV-2 sequences with stable to slightly increasing trend in viral activity and hospitalizations." The new Stratus strain of Covid is currently the "most prevalent" in the UK, according to the UK Health Security Agency (UKHSA). Health organisations are yet to list any symptoms unique to Covid Stratus. However, common symptoms of other COVID-19 variants, according to the NHS, include: COVID-19 vaccines are available in the UK, and are usually offered on the NHS in spring and early winter. The vaccine is available for those: RECOMMENDED READING: The common disease medical experts believe will cause the next global pandemic Am I eligible for free prescriptions? Yes, if you have 1 of these 11 conditions The 6 beers that are good for your health (and the ones to avoid) The NHS said: "The COVID-19 vaccines are offered because viruses change and protection fades over time. It's important to top up your protection if you're eligible." The vaccine helps: Eligible people can book in for a vaccination via the NHS website, the NHS App, or by attending a walk-in COVID-19 vaccination site.
